Atlas Trials

Phase I/II Study of Neoadjuvant Lapatinib in Breast Cancer

Clinical trial NCT00450892 · COMPLETED

Trial details

NCT number
NCT00450892
Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Breast Cancer
Start date
2007-02-01
Primary completion
2013-07-01
Enrollment
129

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.